Guardian Pharmacy executive converts 641,870 shares

Guardian Pharmacy Services, Inc.'s Amended and Restated Certificate of Incorporation provided for the automatic conversion.

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. director and Executive Vice President, Chief Operating Officer David K. Morris reported an automatic one-for-one conversion on September 27, 2026: 641,870 shares of Class B common stock converted into 641,870 shares of Class A common stock. He reported 896,341 shares of Class A common stock following the transaction, excluding 641,870 shares he had agreed to transfer on or before November 11, 2026, under a September 2025 domestic relations order.

Insider Trade Summary

641,870 shares exercised/converted

Exercise 2 txns

Insider Morris David K

Role See Remarks

Type	Security	Shares	Price	Value
Exercise	Class B Common Stock F1	641,870	--	--
Exercise	Class A Common Stock F1, F2	641,870	--	--

Holdings After Transaction: Class B Common Stock — 0 contracts (Direct); Class A Common Stock — 896,341 shares (Direct)

Footnotes (2)

1. F1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.
2. F2. Excludes 641,870 shares of Class A common stock that the Reporting Person has agreed to transfer on or before November 11, 2026 pursuant to a September 2025 domestic relations order, as previously disclosed.

Key Figures

Class B common stock converted: 641,870 shares Class A common stock acquired: 641,870 shares Class A common stock following transaction: 896,341 shares +1 more

4 metrics

Class B common stock converted 641,870 shares Automatic one-for-one conversion on September 27, 2026

Class A common stock acquired 641,870 shares Automatic one-for-one conversion on September 27, 2026

Class A common stock following transaction 896,341 shares Excludes 641,870 shares agreed to be transferred

Class A common stock agreed to be transferred 641,870 shares On or before November 11, 2026, under a September 2025 domestic relations order

Key Terms

Amended and Restated Certificate of Incorporation, domestic relations order, Class B common stock, Class A common stock

4 terms

Amended and Restated Certificate of Incorporation technical

"Pursuant to Guardian Pharmacy Services, Inc.'s Amended and Restated Certificate of Incorporation"

A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.

domestic relations order technical

"pursuant to a September 2025 domestic relations order"

Class B common stock technical

"shares of Class B common stock automatically converted into shares"

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

Class A common stock technical

"shares of the Issuer's Class A common stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GRDN shares did David K. Morris convert?

David K. Morris converted 641,870 shares of Class B common stock into 641,870 shares of Class A common stock on September 27, 2026, automatically and one-for-one.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 05:02 PM Accepted by SEC EDGAR 09/28/2026 - 05:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morris David K

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GEORGIA 30339

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)	X	Other (specify below)
	See Remarks		Member of 10% Owner Group

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/27/2026		M		641,870	A	(1)	896,341(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	(1)	09/27/2026		M			641,870	(1)	(1)	Class A Common Stock	641,870	(1)	0	D

Explanation of Responses:

1. Pursuant to Guardian Pharmacy Services, Inc.'s (the "Issuer") Amended and Restated Certificate of Incorporation, the Reporting Person's shares of Class B common stock automatically converted into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

2. Excludes 641,870 shares of Class A common stock that the Reporting Person has agreed to transfer on or before November 11, 2026 pursuant to a September 2025 domestic relations order, as previously disclosed.

Remarks:

Executive Vice President, Chief Operating Officer

	/s/ Douglas Towns, Attorney-in-Fact	09/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)